In this study, after statistical considerations on evaluating the sample size threshold, a mathematical model and a detailed procedure are given for the estimation of the reaction rate constant and mass transfer coefficient.
After evaluating the 72 patient sample set as described, additional samples were microarrayed to evaluate prevalence of Active subtype as a function of distance to tumor.
After evaluating the number of samples analyzed from each of the 48 continental United States, we identified three regions having sufficient sample size (n=5,676 total) including the Mid-Atlantic, Midwest, and Northeast.
Although samples of visually similar lithology were collected at the outcrops, some variability in sample compositions was found after evaluating the data (mineral contents are given in weight percent).
For this evaluation, samples were not frozen and thawed more than once, and we evaluated the samples immediately after collection (at room temperature).
After the quality of the libraries was evaluated, the samples were sequenced using an Illumina HiSeq 2000 machine.
After evaluating individual samples, we also found that some control samples were significant outliers for the CD83 and SERPINB9 genes.
After evaluating these models in a validation sample (Vanderbilt BioVU cohort), we found that six of the 11 models replicated.
In a pricing study evaluating the effects of anchors, researchers asked subjects to estimate the worth of a sample home.
After evaluating co-occurrence, analysis was carried out to evaluate the exact combination of enteropathogens (fingerprint) present or absent in samples.
The second sample was measured almost every day for 30 days after shaking the fluid, to evaluate the size distribution changes after mechanically recovering the settled particles.
